A citation-based method for searching scientific literature

Luke A Jelen, James M Stone. Int Rev Psychiatry 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression.
Elia E Acevedo-Diaz, Grace W Cavanaugh, Dede Greenstein, Christoph Kraus, Bashkim Kadriu, Carlos A Zarate, Lawrence T Park. J Affect Disord 2020
23
100

Safety of Repeated Administration of Parenteral Ketamine for Depression.
David Feifel, David Dadiomov, Kelly C Lee. Pharmaceuticals (Basel) 2020
5
100

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
Roger S McIntyre, Joshua D Rosenblat, Charles B Nemeroff, Gerard Sanacora, James W Murrough, Michael Berk, Elisa Brietzke, Seetal Dodd, Philip Gorwood, Roger Ho,[...]. Am J Psychiatry 2021
27
100

Hepatic effects of ketamine administration for 2 weeks in rats.
Y Kalkan, Y Tomak, D Altuner, L Tumkaya, H Bostan, A Yilmaz, D Unal, A Kara, A Turan. Hum Exp Toxicol 2014
12
100

Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.
Steven P Cohen, Anuj Bhatia, Asokumar Buvanendran, Eric S Schwenk, Ajay D Wasan, Robert W Hurley, Eugene R Viscusi, Samer Narouze, Fred N Davis, Elspeth C Ritchie,[...]. Reg Anesth Pain Med 2018
78
100

The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis.
Jiaqi Xiong, Orly Lipsitz, David Chen-Li, Joshua D Rosenblat, Nelson B Rodrigues, Isabelle Carvalho, Leanna M W Lui, Hartej Gill, Flora Narsi, Rodrigo B Mansur,[...]. J Psychiatr Res 2021
9
100

Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion.
Steven J Pennybaker, David A Luckenbaugh, Lawrence T Park, Craig A Marquardt, Carlos A Zarate. Biol Psychiatry 2017
9
100

Urinary symptoms and impaired quality of life in female ketamine users: persistence after cessation of use.
R Y K Cheung, S S C Chan, J H S Lee, A W L Pang, K W Choy, T K H Chung. Hong Kong Med J 2011
14
100

Side-effects associated with ketamine use in depression: a systematic review.
Brooke Short, Joanna Fong, Veronica Galvez, William Shelker, Colleen K Loo. Lancet Psychiatry 2018
165
100

Low-dose ketamine for treatment resistant depression in an academic clinical practice setting.
David Feifel, Benjamin Malcolm, Danielle Boggie, Kelly Lee. J Affect Disord 2017
18
100


Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases.
Ingeborg M Noppers, Marieke Niesters, Leon P H J Aarts, Martin C R Bauer, Asbjørn M Drewes, Albert Dahan, Elise Y Sarton. Pain 2011
61
100

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.
Carla M Canuso, Jaskaran B Singh, Maggie Fedgchin, Larry Alphs, Rosanne Lane, Pilar Lim, Christine Pinter, David Hough, Gerard Sanacora, Husseini Manji,[...]. Am J Psychiatry 2018
169
100

Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.
Fernanda S Correia-Melo, Gustavo C Leal, Flávia Vieira, Ana Paula Jesus-Nunes, Rodrigo P Mello, Guilherme Magnavita, Ana Teresa Caliman-Fontes, Mariana V F Echegaray, Igor D Bandeira, Samantha S Silva,[...]. J Affect Disord 2020
41
100

Substantial Elevation of Liver Enzymes During Ketamine Infusion: A Case Report.
Xiaoying Zhu, Lynn R Kohan, Robert B Goldstein. A A Pract 2020
2
100

The prevalence and natural history of urinary symptoms among recreational ketamine users.
Adam R Winstock, Luke Mitcheson, David A Gillatt, Angela M Cottrell. BJU Int 2012
88
100


The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis.
Roger S McIntyre, Isabelle P Carvalho, Leanna M W Lui, Amna Majeed, Prakash S Masand, Hartej Gill, Nelson B Rodrigues, Orly Lipsitz, Alexandria C Coles, Yena Lee,[...]. J Affect Disord 2020
29
100

Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment.
Jason Ng, Leanna M W Lui, Joshua D Rosenblat, Kayla M Teopiz, Orly Lipsitz, Danielle S Cha, Jiaqi Xiong, Flora Nasri, Yena Lee, Kevin Kratiuk,[...]. Psychopharmacology (Berl) 2021
4
100

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, Rama Melkote, Rosanne Lane, Pilar Lim, Dawn Vitagliano, Pierre Blier, Maurizio Fava, Michael Liebowitz,[...]. Int J Neuropsychopharmacol 2019
111
100

The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE).
Roger S McIntyre, Joshua D Rosenblat, Nelson B Rodrigues, Orly Lipsitz, David Chen-Li, Jung Goo Lee, Flora Nasri, Mehala Subramaniapillai, Kevin Kratiuk, Andrew Wang,[...]. Psychiatry Res 2021
2
100

Ketamine and other glutamate receptor modulators for depression in adults.
Caroline Caddy, Ben H Amit, Tayla L McCloud, Jennifer M Rendell, Toshi A Furukawa, Rupert McShane, Keith Hawton, Andrea Cipriani. Cochrane Database Syst Rev 2015
100
100

A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions.
Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, Yena Lee, Danielle S Cha, Margarita Shekotikhina, Maj Vinberg, Hartej Gill, Mehala Subramaniapillai, Kevin Kratiuk,[...]. J Affect Disord 2021
2
100

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Vanina Popova, Ella J Daly, Madhukar Trivedi, Kimberly Cooper, Rosanne Lane, Pilar Lim, Christine Mazzucco, David Hough, Michael E Thase, Richard C Shelton,[...]. Am J Psychiatry 2019
164
100

Midazolam premedication in attenuating ketamine psychic sequelae.
S C Somashekara, D Govindadas, G Devashankaraiah, Rajkishore Mahato, S Deepalaxmi, V Srinivas, J V Murugesh, Devanand. J Basic Clin Pharm 2010
10
100

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
Gerard Sanacora, Mark A Frye, William McDonald, Sanjay J Mathew, Mason S Turner, Alan F Schatzberg, Paul Summergrad, Charles B Nemeroff. JAMA Psychiatry 2017
224
100

The effect of music on ketamine induced emergence phenomena.
A Kumar, A Bajaj, P Sarkar, V K Grover. Anaesthesia 1992
15
100


Short-term ketamine administration in treatment-resistant depression: focus on cardiovascular safety.
Joanna Szarmach, Wiesław Jerzy Cubała, Adam Włodarczyk, Mariusz S Wiglusz. Psychiatr Danub 2019
9
100

A brief measure for assessing generalized anxiety disorder: the GAD-7.
Robert L Spitzer, Kurt Kroenke, Janet B W Williams, Bernd Löwe. Arch Intern Med 2006
100

Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.
Chiara Gastaldon, Emanuel Raschi, John M Kane, Corrado Barbui, Georgios Schoretsanitis. Psychother Psychosom 2021
10
100

Development of the Ketamine Side Effect Tool (KSET).
Brooke Short, Vanessa Dong, Verònica Gálvez, Vedran Vulovic, Donel Martin, Adam J Bayes, Carlos A Zarate, James W Murrough, Declan M McLoughlin, Patricio Riva-Posse,[...]. J Affect Disord 2020
6
100

Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence.
Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, Yena Lee, Danielle S Cha, Flora Nasri, Hartej Gill, Leanna M W Lui, Mehala Subramaniapillai, Kevin Kratiuk,[...]. Expert Opin Drug Saf 2020
7
100

Pharmacodynamic and pharmacokinetic interactions between ketamine and diazepam.
J Idvall, K F Aronsen, P Stenberg, L Paalzow. Eur J Clin Pharmacol 1983
21
100

Esketamine for treatment resistant depression: a trick of smoke and mirrors?
C Gastaldon, D Papola, G Ostuzzi, C Barbui. Epidemiol Psychiatr Sci 2019
15
100

The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder.
Roger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, Yena Lee, Danielle S Cha, Maj Vinberg, Kangguang Lin, Gin S Malhi, Mehala Subramaniapillai, Kevin Kratiuk,[...]. Bipolar Disord 2020
12
100

Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review.
Matthew D Cooper, Joshua D Rosenblat, Danielle S Cha, Yena Lee, Ron Kakar, Roger S McIntyre. World J Biol Psychiatry 2017
21
100

Wherefore ketamine?
Jan Persson. Curr Opin Anaesthesiol 2010
42
100

Dissociative and Analgesic Properties of Ketamine Are Independent.
Jacob Gitlin, Shubham Chamadia, Joseph J Locascio, Breanna R Ethridge, Juan C Pedemonte, Eunice Y Hahm, Reine Ibala, Jennifer Mekonnen, Katia M Colon, Jason Qu,[...]. Anesthesiology 2020
5
100

Managing dissociative symptoms following the use of esketamine nasal spray: a case report.
Sophia Pereira, Emily Brennan, Anjali Patel, Melissa Moran, Jenny Wallier, Michael R Liebowitz. Int Clin Psychopharmacol 2021
4
100

Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions.
Patricio Riva-Posse, Collin M Reiff, Johnathan A Edwards, Gregory P Job, Gail C Galendez, Steven J Garlow, Tammy C Saah, Boadie W Dunlop, William M McDonald. J Affect Disord 2018
32
100


A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.
Jaskaran B Singh, Maggie Fedgchin, Ella J Daly, Peter De Boer, Kimberly Cooper, Pilar Lim, Christine Pinter, James W Murrough, Gerard Sanacora, Richard C Shelton,[...]. Am J Psychiatry 2016
231
100

Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression.
Joanna Szarmach, Wiesław Jerzy Cubała, Adam Włodarczyk, Maria Gałuszko-Węgielnik. Medicina (Kaunas) 2021
2
100

General anesthesia and altered states of arousal: a systems neuroscience analysis.
Emery N Brown, Patrick L Purdon, Christa J Van Dort. Annu Rev Neurosci 2011
243
100

Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Jennifer L Phillips, Sandhaya Norris, Jeanne Talbot, Meagan Birmingham, Taylor Hatchard, Abigail Ortiz, Olabisi Owoeye, Lisa A Batten, Pierre Blier. Am J Psychiatry 2019
115
100

Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program.
Teodora Doherty, Ewa Wajs, Rama Melkote, Janice Miller, Jaskaran B Singh, Michael A Weber. CNS Drugs 2020
15
100

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.
Jaskaran B Singh, Maggie Fedgchin, Ella Daly, Liwen Xi, Caroline Melman, Geert De Bruecker, Andre Tadic, Pascal Sienaert, Frank Wiegand, Husseini Manji,[...]. Biol Psychiatry 2016
186
100

Administration of ketamine for unipolar and bipolar depression.
Christoph Kraus, Ulrich Rabl, Thomas Vanicek, Laura Carlberg, Ana Popovic, Marie Spies, Lucie Bartova, Gregor Gryglewski, Konstantinos Papageorgiou, Rupert Lanzenberger,[...]. Int J Psychiatry Clin Pract 2017
54
100

The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence.
Roger S McIntyre, Nelson B Rodrigues, Yena Lee, Orly Lipsitz, Mehala Subramaniapillai, Hartej Gill, Flora Nasri, Amna Majeed, Leanna M W Lui, Olena Senyk,[...]. J Affect Disord 2020
26
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.